Generalized keratosis pilaris-like eruptions in a chronic myelogenous leukemia patient treated with nilotinib

MeSH terms

• Administration, Cutaneous
• Aged
• Antineoplastic Agents / adverse effects*
• Antineoplastic Agents / therapeutic use
• Drug Eruptions / blood
• Drug Eruptions / diagnosis*
• Drug Eruptions / drug therapy
• Drug Eruptions / pathology
• Female
• Fusion Proteins, bcr-abl / antagonists & inhibitors
• Humans
• Keratolytic Agents / administration & dosage
• Keratolytic Agents / therapeutic use
• Keratosis / blood
• Keratosis / chemically induced
• Keratosis / diagnosis*
• Keratosis / drug therapy
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
• Lower Extremity
• Molecular Targeted Therapy / adverse effects*
• Protein Kinase Inhibitors / adverse effects*
• Protein Kinase Inhibitors / therapeutic use
• Pyrimidines / adverse effects*
• Pyrimidines / therapeutic use
• Salicylic Acid / administration & dosage
• Salicylic Acid / therapeutic use
• Torso
• Upper Extremity